Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -405,124 | -189,424 | -1,079,586 | -860,414 | -628,621 |
| Depreciation Amortization | 90 | 44 | 146 | 104 | 62 |
| Accounts payable and accrued liabilities | 2,895 | 6,802 | 15,303 | 17,448 | 18,287 |
| Other Working Capital | 7,088 | -1,675 | 31,416 | 23,080 | 15,219 |
| Other Operating Activity | 131,636 | 61,962 | 709,791 | 598,790 | 467,141 |
| Operating Cash Flow | $-263,415 | $-122,291 | $-322,930 | $-220,992 | $-127,912 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 223,812 | 7 | -173,653 | 311,340 | 311,340 |
| PPE Investments | -1,154 | -245 | -657 | -493 | -422 |
| Investing Cash Flow | $222,658 | $-238 | $-174,310 | $310,847 | $310,918 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 234,875 | 3,797 | 617,533 | 43,712 | 2,584 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 7,315 |
| Financing Cash Flow | $234,875 | $3,797 | $617,533 | $43,712 | $9,899 |
| Exchange Rate Effect | -18 | -19 | 102 | 121 | 99 |
| Beginning Cash Position | 225,582 | 225,582 | 105,187 | 105,187 | 105,187 |
| End Cash Position | 419,682 | 106,831 | 225,582 | 238,875 | 298,191 |
| Net Cash Flow | $194,100 | $-118,751 | $120,395 | $133,688 | $193,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | -263,415 | -122,291 | -322,930 | -220,992 | -127,912 |
| Capital Expenditure | -1,154 | -245 | -657 | -493 | -422 |
| Free Cash Flow | -264,569 | -122,536 | -323,587 | -221,485 | -128,334 |